About
Technology
Issues
FAQ
Links
Official Page
EPHA2 Is a Mediator of Vemurafenib Resistance and a Novel Therapeutic Target in Melanoma
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.